Behavioural side effects of inhaled corticosteroids among children and adolescents with asthma.

ABSTRACT:

Background

Inhalation corticosteroids (ICS) are prescribed for treatment of asthma in approximately 3% of all children in Denmark. Despite limited evidence, case reports suggest that ICS-related behavioural adverse drug events (ADEs) may be frequent. In general, underreporting of ADEs to official databases is common, and little is known about doctor's clinical experiences with behavioural ADEs when prescribing ICS for children with asthma. The objective was to investigate the extent of behavioural ADEs in children with asthma treated with ICS by comparing database findings to experiences of specialist doctors.

Methods

First, databases of the European Medicines Agency (EMA) and the Danish Medicines Agency (DKMA) were searched for reports made by healthcare professionals about

SUBMITTER: Bodum KS 

PROVIDER: S-EPMC9330944 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature